Melanoma divided according to the driving mutations also has four subtypes: BRAF-mutant, NRAS-mutant, NF1-loss, and TWT. The BRAF, NRAS, and NF1 mutations activate the mitogen-activated protein kinase (MAPK) pathway and usually occur during the early stage of tumour (30). This evidence concerns the gene NRAS and neoplasm.